These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 38411629)

  • 21. Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action.
    Dos Santos RG; Hallak JE; Baker G; Dursun S
    J Psychopharmacol; 2021 Apr; 35(4):453-458. PubMed ID: 33740877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antidepressant Efficacy and Tolerability of Ketamine and Esketamine: A Critical Review.
    Molero P; Ramos-Quiroga JA; Martin-Santos R; Calvo-Sánchez E; Gutiérrez-Rojas L; Meana JJ
    CNS Drugs; 2018 May; 32(5):411-420. PubMed ID: 29736744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Psychedelics for existential distress in terminally ill patients].
    Schimmel N; Breeksema JJ; Veraart JKE; van den Brink W; Schoevers RA
    Tijdschr Psychiatr; 2020; 62(8):659-668. PubMed ID: 32816294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prophylactic effects of arketamine, but not hallucinogenic psychedelic DOI nor non-hallucinogenic psychedelic analog lisuride, in lipopolysaccharide-treated mice and mice exposed to chronic restrain stress.
    Liu G; Ma L; Qu Y; Wan X; Xu D; Zhao M; Murayama R; Hashimoto K
    Pharmacol Biochem Behav; 2023 Dec; 233():173659. PubMed ID: 37844631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychedelics in the treatment of unipolar and bipolar depression.
    Bosch OG; Halm S; Seifritz E
    Int J Bipolar Disord; 2022 Jul; 10(1):18. PubMed ID: 35788817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mystical-type experiences occasioned by ketamine mediate its impact on at-risk drinking: Results from a randomized, controlled trial.
    Rothberg RL; Azhari N; Haug NA; Dakwar E
    J Psychopharmacol; 2021 Feb; 35(2):150-158. PubMed ID: 33307947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ketamine for Depression: Advances in Clinical Treatment, Rapid Antidepressant Mechanisms of Action, and a Contrast with Serotonergic Psychedelics.
    Kojic M; Saelens J; Kadriu B; Zarate CA; Kraus C
    Curr Top Behav Neurosci; 2022; 56():141-167. PubMed ID: 35312993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reconsidering "dissociation" as a predictor of antidepressant efficacy for esketamine.
    Mathai DS; Nayak SM; Yaden DB; Garcia-Romeu A
    Psychopharmacology (Berl); 2023 Apr; 240(4):827-836. PubMed ID: 36729145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics.
    Savalia NK; Shao LX; Kwan AC
    Trends Neurosci; 2021 Apr; 44(4):260-275. PubMed ID: 33358035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Esketamine and Psilocybin-The Comparison of Two Mind-Altering Agents in Depression Treatment: Systematic Review.
    Psiuk D; Nowak EM; Dycha N; Łopuszańska U; Kurzepa J; Samardakiewicz M
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of ketamine optical isomers, psilocybin, psilocin and norpsilocin on time estimation and cognition in rats.
    Popik P; Hogendorf A; Bugno R; Khoo SY; Zajdel P; Malikowska-Racia N; Nikiforuk A; Golebiowska J
    Psychopharmacology (Berl); 2022 Jun; 239(6):1689-1703. PubMed ID: 35234983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring the Molecular Targets for the Antidepressant and Antisuicidal Effects of Ketamine Enantiomers by Using Network Pharmacology and Molecular Docking.
    Altê GA; Rodrigues ALS
    Pharmaceuticals (Basel); 2023 Jul; 16(7):. PubMed ID: 37513925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Qualitative and Quantitative Features of Music Reported to Support Peak Mystical Experiences during Psychedelic Therapy Sessions.
    Barrett FS; Robbins H; Smooke D; Brown JL; Griffiths RR
    Front Psychol; 2017; 8():1238. PubMed ID: 28790944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ketamine, psilocybin, and rapid acting antidepressant: new promise for psychiatry?].
    Bottemanne H; Claret A; Fossati P
    Encephale; 2021 Apr; 47(2):171-178. PubMed ID: 33190819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice.
    Takaba R; Ibi D; Yoshida K; Hosomi E; Kawase R; Kitagawa H; Goto H; Achiwa M; Mizutani K; Maede K; González-Maeso J; Kitagaki S; Hiramatsu M
    Res Sq; 2023 Jul; ():. PubMed ID: 37461593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human behavioral pharmacology of psychedelics.
    Strickland JC; Johnson MW
    Adv Pharmacol; 2022; 93():105-132. PubMed ID: 35341564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Buddhist-like opposite diminishing and non-judging during ketamine infusion are associated with antidepressant response: an open-label personalized-dosing study.
    Stocker K; Hartmann M; Reissmann S; Kist A; Liechti ME
    Front Pharmacol; 2022; 13():916641. PubMed ID: 35959442
    [No Abstract]   [Full Text] [Related]  

  • 38. Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?
    Husain MI; Ledwos N; Fellows E; Baer J; Rosenblat JD; Blumberger DM; Mulsant BH; Castle DJ
    Front Psychiatry; 2022; 13():1076459. PubMed ID: 36844032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of ketamine action as an antidepressant.
    Zanos P; Gould TD
    Mol Psychiatry; 2018 Apr; 23(4):801-811. PubMed ID: 29532791
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.